Selective inhibition of human translation termination by a drug-like compound
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Chang, Stacey Tsai-Lan
Ward, Fred. R.
Cate, Jamie H. D.
Text and Data Mining valid from 2020-10-02
Version of Record valid from 2020-10-02
11 June 2020
11 September 2020
2 October 2020
J.H.D.C. is a co-founder of Initial Therapeutics. The remaining authors declare no competing interests.